Hip fracture device study pulled before it began
NCT ID NCT05559736
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study was designed to test a new metal implant called the Artemis Proximal Femoral Nail for fixing a common type of hip fracture. The plan was to compare results from patients who received this implant to similar patients from the past who received other implants. However, the study was withdrawn before any participants were enrolled, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Artemis Proximal Femoral Nail (PFN) implant
- What this could lead to
- If successful, this could provide a safe and effective option for surgically fixing certain hip fractures.
- What could go wrong
- This trial was withdrawn before enrolling any participants, so no data is available. The device already has FDA clearance, but this pilot study was never conducted.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Started
-
May 2023
- Expected to finish
-
Jun 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * All patients with traumatic, non-pathologic stable intertrochanteric fractures requiring cephalomedullary nail fixation Exclusion Criteria: * Pediatric patients (\<18 years) * Pregnant females * Patients with other concomitant orthopaedic injuries
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Femoral fracture are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Johns Hopkins Bayview Medical Center
Baltimore, Maryland, 21244, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a cementless hip stem hold up in asian patients?
- Can a bone marrow injection save young hips after fracture?
- Could a simple drink rebuild strength after a hip fracture?
- Robots vs. hands: a precision showdown for hip fracture surgery
- New hip fracture fixation device put to the test against traditional screws
- Anesthesia choice may influence blood loss in hip fracture surgery